Do people actually lose weight on Wegovy — and how much?

What the STEP 1 numbers actually mean for a real person

The ~15% average from STEP 1 is exactly that, an average. Some participants lost considerably more; others lost less. At the highest end, roughly a third of people on semaglutide 2.4mg in that trial lost 20% or more of their body weight. At the other end, a portion lost under 5%. Averages flatten that spread, so it is worth holding the full picture rather than treating 15% as a personal guarantee.

What the trial also showed was that weight loss is not immediate. The dose titration schedule (starting at a low dose and stepping up roughly every four weeks) means the first couple of months are more about tolerability than dramatic results. Most people do not reach the 2.4mg maintenance dose until around week 16 to 20. The pattern of when weight loss typically begins matters if you are trying to set realistic expectations.

The trial ran for 68 weeks. Weight loss continued beyond the first few months for most participants, with the steepest change often happening in months three through nine. That trajectory is partly why short-term assessments can be misleading.

Why some people lose less weight than the trial average

If the evidence is strong, why do some people not see the results they hoped for? Several factors are well-established. Adherence matters a great deal: missing doses, not completing the titration, or stopping early all reduce the medicine's effect. Calorie intake is still relevant, Wegovy reduces appetite significantly, but it does not override a diet that remains very high in processed foods and excess calories.

There are also biological differences in how people respond to GLP-1 medicines. Body composition, existing metabolic conditions and medication interactions all play a role. The reasons behind limited response are worth understanding before starting, not after three months of frustration.

NICE guidance on semaglutide (TA875) recommends considering stopping treatment if less than 5% weight loss has occurred after six months at the maintenance dose, as set out in the NICE appraisal. That is not a failure verdict, it is a clinical signal that the medicine may not be the right fit for that individual.

The role of lifestyle: what Wegovy does and does not do for you

Wegovy reduces appetite and slows gastric emptying. That physiological shift makes it easier to eat less without constant willpower effort, which is a genuine therapeutic advantage. It does not, however, replace the need for a reduced-calorie diet and regular physical activity. All the trial participants received structured dietary and lifestyle support alongside the injection, and the licence reflects that: Wegovy is approved as an adjunct to these changes, not as a standalone treatment.

Protein intake and strength training are particularly relevant here. Because weight loss on Wegovy includes some lean muscle mass alongside fat, preserving muscle through adequate protein and resistance exercise helps with both body composition and long-term metabolic health. Your prescriber or a registered dietitian can help you build a practical plan around treatment.

It is also worth knowing that weight commonly returns when Wegovy is stopped. The evidence on weight regain after stopping is clear enough that it should factor into any decision about starting treatment in the first place. This is a long-term commitment, not a short-term fix.

The practical question: is Wegovy right for your situation?

If you are at this page, you are probably weighing up whether the evidence translates into something that could work for you specifically. That is the right question to be asking. The trial data is reassuring for most people; the variability means individual assessment matters.

Wegovy (semaglutide) is licensed in the UK for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A fuller overview of the treatment is on the Wegovy treatment page.

The financial side is a real consideration too. Private Wegovy costs vary by dose and provider, and it is worth understanding what is included in any price you see quoted. At nume, one transparent price covers the consultation, prescription, treatment and next-working-day delivery, no subscription, no hidden fees. Whether the cost makes sense for your circumstances is part of the decision, and a prescriber conversation is the place to work through it properly.

Ready to talk it through? Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not by an algorithm.